In vivo tracking of mesenchymal stem cells labeled with a novel chitosan-coated superparamagnetic iron oxide nanoparticles using 3.0T MRI

Journal of Korean Medical Science

Volumn 25, Issue 2, 2010, Pages 211-219

  Reddy, Alavala Matta ^a,d   Kwak, Byung Kook ^a   Shim, Hyung Jin ^a   Ahn, Chiyoung ^b   Lee, Hyo Sook ^c   Suh, Yong Jae ^c   Park, Eon Sub ^a  

^a Chung Ang University College of Medicine   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c Div of Minerals Utiliz and Mat   (South Korea)

^d ADIKAVI NANNAYA UNIVERSITY   (India)

Author keywords

Brain ischemia; Chitosan; Magnetic resonance imaging; Mesenchymal stem cells; Superparamagnetic iron oxide

Indexed keywords

CHITOSAN; COORDINATION COMPOUND; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

ANIMAL; ARTICLE; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; HUMAN; MAGNETISM; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PHENOTYPE; RABBIT;

ANIMALS; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CHITOSAN; COORDINATION COMPLEXES; FERRIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; METAL NANOPARTICLES; PHENOTYPE; RABBITS;

EID: 77951631196     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.2.211     Document Type: Article

References (20)

1. Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol 2000; 28: 875-84.
2. Stauer BE, Kornowski R. Stem cell therapy in perspective. Circulation 2003; 107: 929-34.
3. Berry CC, Wells S, Charles S, Curtis AS. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 2003; 24: 4551-7.
4. Harris LA, Goff JD, Carmichael AY, Riffle JS, Harburn JJ, St Pierre TG, Saunders M. Magnetic nanoparticle dispersions stabilized with triblock copolymers. Chem Mater 2003; 15: 1367-77.
5. Kim EH, Lee HS, Kwak BK, Kim BK. Synthesis of ferrofluid with magnetic nanoparticles by sonochemical method for MRI contrast agent. J Magn Magn Mater 2005; 289: 328-30.
6. Lee HS, Shao H, Huang Y, Kwak BK. Synthesis of MRI contrast agent by coating superparamagnetic iron oxide with chitosan. IEEE Trans Magn 2005; 41: 4102-4.
7. Sinha VR, Singla AK, Wadhawan S, Kaushik R, Kumaria R, Bansal K, Dhawan, S. Chitosan microspheres as a potential carrier for drugs. Int J Pharm 2004; 274: 1-33.
8. Wang YX, Hussain SM, Krestin GP. Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001; 11: 2319-31.
9. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 1994; 134: 277-86.
10. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF. Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 1998; 4: 415-28.
11. Bowen CV, Zhang X, Saab G, Gareau PJ, Rutt BK. Application of the static dephasing regime theory to superparamagnetic iron-oxide loaded cells. Magn Reson Med 2002; 48: 52-61.
12. Arbab AS, Bashaw LA, Miller BR, Jordan EK, Lewis BK, Kalish H, Frank JA, Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003; 229: 838-46.
13. Arbab AS, Yocum GT, Kalish H, Jordan EK, Anderson SA, Khakoo AY, Read EJ, Frank JA. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004; 104: 1217-23.
14. Ittrich H, Lange C, Tögel F, Zander AR, Dahnke H, Westenfelder C, Adam G, Nolte-Ernsting C. In vivo magnetic resonance imaging of iron oxide labeled arterially injected mesenchymal stem cells in kidney of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 2007; 25: 1179-91.
15. Kostura L, Kraitchman DL, Mackay AM, Pittenger MF, Bulte JW. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 2004; 17: 513-7.
16. Bulte JW, Kratchman DL, Mackay AM, Pittenger MF. Chondrogenic differentiation of mesenchymal stem cells is inhibited after magnetic labeling with ferumoxides. Blood 2004; 104: 3410-3.
17. Arbab AS, Yocum GT, Rad AM, Khakoo AY, Fellowes V, Read EJ, Frank JA. Labeling of cells with ferumoxides. Protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoitic or mesenchymal stem cells. NMR Biomed 2005; 18: 553-9.
18. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, Tsukamoto Y, Iso H, Fujimori Y, Stern DM, Naritomi H, Matsuyama T. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 2004; 114: 330-8.
19. Werner N, Junk S, Laufs U, Link A, Walenta K, Bohm M, Nickenig G. Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 2003; 93: e17-24.
20. Newcomb CD, Ajmo CT Jr, Sanberg CD, Sanberg PR, Pennypacker KR, Willing AE. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant 2006; 15: 213-23.